Span Divergent Q1 Results: Consolidated loss widens to ₹118.82 lakhs
Span Divergent Ltd posted a consolidated net loss of ₹118.82 lakhs in Q1FY27, up from ₹17.01 lakhs in Q1FY26, due to weak cashew processing revenues. Standalone net loss was ₹4.22 lakhs. Subsidiaries continue to face substantial accumulated losses, with Biospan Contamination Control Solutions showing negative net worth.

*this image is generated using AI for illustrative purposes only.
Span Divergent reported a consolidated net loss of ₹118.82 lakhs for the first quarter ended June 30, 2026 (Q1FY27), a significant deterioration from the consolidated net loss of ₹17.01 lakhs recorded in the corresponding period of FY26. The widening loss was primarily attributed to severe underperformance in its core cashew processing segment, where revenue plummeted while operating losses expanded. Standalone operations also turned negative, reporting a net loss of ₹4.22 lakhs compared to a net profit of ₹41.67 lakhs in Q1FY26.
The Board of Directors approved the unaudited financial results on August 11, 2026. The figures were reviewed by the Audit Committee and subjected to a limited review by the statutory auditors, Y. B. Desai & Associates, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The financial statements have been prepared in accordance with Indian Accounting Standards (Ind AS) notified under Section 133 of the Companies Act, 2013.
Consolidated Financial Performance
Consolidated revenue from operations dropped sharply to ₹102.55 lakhs in Q1FY27, down from ₹126.61 lakhs in Q1FY26. This decline was driven by the cashew processing segment, which generated only ₹35.41 lakhs in revenue, a fraction of the ₹379.56 lakhs recorded in the preceding quarter (Q4FY26). The trading segment contributed ₹67.14 lakhs, down from ₹111.34 lakhs in the year-ago quarter.
Total expenses stood at ₹244.77 lakhs, leading to an operating loss before interest and tax of ₹114.57 lakhs. Finance costs increased to ₹13.67 lakhs from ₹11.92 lakhs in Q1FY26. Deferred tax expense added ₹4.25 lakhs to the bottom line pressure.
| Metric | Q1FY27 (₹ Lakhs) | Q1FY26 (₹ Lakhs) | Change |
|---|---|---|---|
| Revenue from Operations | 102.55 | 126.61 | -19.0% |
| Total Expenses | 244.77 | 212.67 | +15.1% |
| Profit/(Loss) Before Tax | (114.57) | (14.46) | Widened |
| Net Profit/(Loss) | (118.82) | (17.01) | Widened |
Standalone Results and Segment Issues
On a standalone basis, total income fell to ₹30.83 lakhs from ₹64.93 lakhs in Q1FY26. Other operating income, comprising interest on fluctuating capital provided to LLP subsidiaries and management fees, declined to ₹13.45 lakhs from ₹38.45 lakhs. Total expenses rose to ₹46.56 lakhs from ₹41.19 lakhs, largely due to higher other expenses of ₹14.00 lakhs compared to ₹7.99 lakhs in the prior year.
The company disclosed significant challenges within its subsidiaries. Aranya Consulting and Biotech LLP had accumulated losses of ₹1,494 lakhs as of March 31, 2026. Biospan Contamination Control Solutions Pvt. Ltd reported accumulated losses of ₹742 lakhs as of June 30, 2026, with total liabilities exceeding total assets by ₹752 lakhs. Despite these deficits, management continues to prepare financial results on a going concern basis, citing plans for product introductions and potential business tie-ups to revive operations.
What the Numbers Show
The divergence between standalone and consolidated performance highlights the heavy drag from subsidiary operations. While the standalone entity managed to contain its loss to ₹4.22 lakhs through lower income but controlled core expenses, the consolidated group absorbed massive operating losses from the cashew processing unit. The cashew segment incurred a pre-tax loss of ₹81.93 lakhs despite generating ₹35.41 lakhs in revenue, indicating a fundamental mismatch between current scale and fixed cost structures. Furthermore, the unutilized proceeds of ₹127.04 lakhs from the March 2026 preferential issue remain available for stated objects, including raw cashew nut inventory procurement, suggesting management intends to ramp up working capital to address these operational gaps.
Historical Stock Returns for Span Divergent
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.15% | +10.82% | -7.00% | -4.09% | +67.92% | +152.07% |
How does management plan to utilize the ₹127.04 lakhs in unutilized preferential issue proceeds to specifically address the cashew segment's working capital deficit and reverse its revenue decline?
Given that Biospan Contamination Control Solutions has liabilities exceeding assets by ₹752 lakhs, what is the timeline and specific criteria for evaluating potential business tie-ups or restructuring to ensure viability?
What operational restructuring measures are being considered for the cashew processing unit to align fixed costs with current revenue levels and stop the widening operating losses?





























